A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy

  • Eun Seok Jeon
  • , Sang Wook Lim
  • , Seok Yeon Kim
  • , Hyoung Mo Yang
  • , Moo Hyun Kim
  • , Moo Yong Rhee
  • , Seung Hwan Han
  • , Jinho Shin
  • , Kwang il Kim
  • , Jin Ok Jeong
  • , Ki Chul Sung
  • , Geu Ru Hong
  • , Hyung Seop Kim
  • , Kihwan Kwon
  • , Tae Soo Kang
  • , Hae Young Lee
  • , Su Eun Han

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience